Sino Medical Sciences Technology, Inc. engages in the research, development, production, and sale of interventional medical devices. It offers coronary stents and balloons, as well as neurovascular and structural heart disease products. The company was founded on September 21, 2007 and is headquartered in Tianjin, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company